<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04990011</url>
  </required_header>
  <id_info>
    <org_study_id>amnion chorion-2019</org_study_id>
    <nct_id>NCT04990011</nct_id>
  </id_info>
  <brief_title>Amnion Chorion Membrane and Oroantral Communication</brief_title>
  <official_title>Evaluation of Amnion Chorion Membrane in the Repair of Oro Antral Communication</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hams Hamed Abdelrahman</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alexandria University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An oroantral communication is a relatively common yet, serious complication following the&#xD;
      extraction of posterior maxillary teeth because of their close relationship to the maxillary&#xD;
      sinus.&#xD;
&#xD;
      Several surgical techniques exist for the repair of oroantral communication, including local&#xD;
      and free flaps, tissue expansion, allogenic tissue, and biomaterials.&#xD;
&#xD;
      The present study aims to evaluate the use of the BioXclude amnion chorion membrane in the&#xD;
      repair of oroantral communication.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be performed on ten patients who have oroantral communication after&#xD;
      extracting posterior maxillary teeth. The oroantral communication will be repaired by using&#xD;
      the BioXclude amnion chorion membrane.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>success of surgery</measure>
    <time_frame>1 month</time_frame>
    <description>Surgery will be considered successful in case of negative nose-blowing 1-month postoperatively, absence of infection, absence of dehiscence or other healing complication</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain level</measure>
    <time_frame>12 hours</time_frame>
    <description>Post-operative pain measure by patients rating 12 h after surgery using visual analogue scale (VAS) of 100 unit on three-point scale with: 0-34 as mild pain, 35 - 64 as moderate pain and 65 - 100 as severe pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in bone formation</measure>
    <time_frame>at 3rd, 6th months</time_frame>
    <description>Evaluation of bone formation at the communication site by computed tomography will be measured at 3 months and 6 months post operatively</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Oroantral Communication</condition>
  <arm_group>
    <arm_group_label>BioXclude amnion chorion membrane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>BioXclude amnion chorion membrane</intervention_name>
    <description>The OAC will be closed by the Bioxclude ACM Amnion chorion membrane which is applied over the extraction socket then supported with a buccal advanced flap.</description>
    <arm_group_label>BioXclude amnion chorion membrane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients should be free of any relevant systemic diseases.&#xD;
&#xD;
          -  Patients with recent oroantral communication (O.A.C) (24:72) hours .&#xD;
&#xD;
          -  Good oral hygiene&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  An immune compromised state.&#xD;
&#xD;
          -  Previous sinus disease.&#xD;
&#xD;
          -  History of sinus surgery.&#xD;
&#xD;
          -  Presence of intra-antral foreign bodies and need for cold well-luc procedure.&#xD;
&#xD;
          -  Presence of intra-sinus pathology&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hala A El awamy, BDS</last_name>
    <phone>01028498333</phone>
    <phone_ext>002</phone_ext>
    <email>halaebeid07@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Alexandria Faculty of Dentistry</name>
      <address>
        <city>Alexandria</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hala A El awamy, BDS</last_name>
      <phone>01028498333</phone>
    </contact>
    <investigator>
      <last_name>Hala A El awamy, BDS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 8, 2021</study_first_submitted>
  <study_first_submitted_qc>July 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 4, 2021</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Alexandria University</investigator_affiliation>
    <investigator_full_name>Hams Hamed Abdelrahman</investigator_full_name>
    <investigator_title>Assistant lecturer of DPH and Clinical statistician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oroantral Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

